CEACAM6 and gastric carcinoma: The rate of samples positive for CEACAM6 was 62.9% (78/124) in gastric carcinoma specimens with poorly differentiated tumors, which was higher than that with well to moderately differentiated tumors (35.3%, 24/68, p < 0.001).